This message was sent to ##Email##
|
|
|
|
|
| |
AST
Spread the word about AST and all it has to offer to continue to strengthen the Society!
New this year - All members who successfully recruit 3 new members will receive 1 year of membership free! In addition, you will be entered into the yearly prize drawing, which includes an iPad or AST bucks!
Don't forget to mention - through the end of August, the AST offers pro-rated dues amounts for new members. Trainees may join at just $45 and full members at just $270! View all rates here.
Quickly send your colleagues a professional request to join via our easy referral form.
Spread the word! Recommend colleagues for membership and earn rewards! Visit the Member-Get-A-Member page for program details and other resources.
AST
Transplantation was founded on the spirit of innovation and experimentation. The AST created the Innovation Award to honor an individual or team whose big ideas and outside the box thinking has made a significant impact on transplantation. The award is designed to showcase successes in transplant innovation and to drive, recognize, and reward novel ideas.
READ MORE
AST
The AST is seeking applications for its annual faculty development and fellowship grants. These applications are open now through November 1, 2018.
READ MORE
|
|
|
|
|
| |
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career – from basic trainee lessons to webinars on specialized topics. Learn More
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
AST
Epigenetic Modifications of Immune Cells and their Importance for Alloimmunity
September 12, 2018 | 2 pm ET | Online Activity
For more information, click here.
AST
Optimizing Viral Diagnostics in Organ Transplantation: The Long and Winding Road
After participating in this webinar, the learner will be able to:
- Describe the limitations of current viral assays to diagnose CMV, EBV, and BK polyomavirus.
- Discuss the emerging diagnostic testing including host responses for CMV and BK polyoma virus.
- Describe the emerging concepts of the immune response to EBV that permit transition from infection to Post-Transplant Lymphoproliferative Disease.
READ MORE
FDA
The Food and Drug Administration is announcing the following public workshop titled “Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment. This public workshop is planned and presented in collaboration with the Transplant Therapeutics Consortium (TTC), a public-private partnership between the FDA, transplantation societies and members of the pharmaceutical and biotechnology industries, founded by the American Society of Transplantation (AST), the American Society of Transplant Surgeons (ASTS), and Critical Path Institute (C-Path) in March 2017. The workshop is intended to discuss potential candidate biomarkers to determine organ transplant patients’ immunologic risk for organ rejection or tolerance.
READ MORE
ASN
Present your late-breaking research to 13,000 kidney professionals at the world's premier nephrology meeting. ASN is now accepting late-breaking clinical trial submissions online through Wednesday, September 5 (2:00 p.m. EDT). Submissions should discuss randomized Phase II and III trials that will have significant impact on clinical practice.
READ MORE
Journal of Hepatology
Direct-acting antivirals (DAAs) have dramatically improved the outcome of patients with hepatitis C virus (HCV) infection including those with decompensated cirrhosis (DC). We analyzed the evolution of indications and results of liver transplantation (LT) in the past 10 years in Europe, focusing on the changes induced by the advent of DAAs.
READ MORE
Hepatology
Liver transplant (LT) decisions in pediatric acute liver failure (PALF) are complex. Three phases of the PALF registry, containing data on 1144 participants over 15 years, were interrogated to characterize clinical features associated with listing status. A decrease in the cumulative incidence (CI) of listing (p<0.005) and receiving (p<0.05) LT occurred without an increase in the CI of death (p=0.67).
READ MORE
Journal of Hepatology
Multiple organ failures (OF) are common in patients with cirrhosis, but the independent effect of number or type of OF on liver transplant (LT) outcomes is not well defined. UNOS data were analyzed from 2002 to 2016 of all adults listed for LT who received LT within 30 days after listing. We estimated post-LT survival stratified by number and type of pre-transplant OF before and after adjusting for confounding variables.
READ MORE
Journal of the American Society of Nephrology
The process for evaluating kidney transplant candidates and applicable centers is distinct for patients with Veterans Administration (VA) coverage. We compared transplant rates between candidates on the kidney waiting list with VA coverage and those with other primary insurance.
READ MORE
Hepatology
We read with interest the paper by Bari and collogues reporting a higher than expected rate of HCV transmission when utilizing liver allografts from nonviremic HCV seropositive donors for HCV seronegative recipients. In this small single center prospective cohort, 25 non‐HCV patients received allografts from high risk donors who were HCV seropositive but nucleic acid testing (NAT) negative. Four recipients (16 percent) developed HCV viremia post transplantation, a rate much higher than previously anticipated.
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
